(Q35017237)

5 August 2017

Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. (English)

1 reference

5 August 2017

Dong-Wei Dai

1

1 reference

5 August 2017

Qiong Lu

2

1 reference

5 August 2017

Lai-Xing Wang

3

1 reference

5 August 2017

Wen-Yuan Zhao

4

1 reference

5 August 2017

Yi-Qun Cao

5

1 reference

5 August 2017

Ya-Nan Li

6

1 reference

5 August 2017

Guo-Sheng Han

7

1 reference

5 August 2017

Jian-Min Liu

8

1 reference

5 August 2017

Zhi-Jian Yue

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

14 October 2013

1 reference

5 August 2017

1 reference

5 August 2017

13

1 reference

5 August 2017

478

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-478

5 August 2017

0 references

cites work

MiR-106a is an independent prognostic marker in patients with glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Colorectal cancer migration and invasion initiated by microRNA-106a

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

DNA damage-induced modulation of GLUT3 expression is mediated through p53-independent extracellular signal-regulated kinase signaling in HeLa cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

AmiGO: online access to ontology and annotation data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Detection of miR-106a in gastric carcinoma and its clinical significance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3853007

Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-13-478

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-13-478

GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-13-478

21 January 2018

Identifiers

DOI

10.1186/1471-2407-13-478

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference